Ginkgo Bioworks announced on April 3, 2025, a partnership between its Ginkgo Datapoints service and Plex Research, a biotechnology company specializing in autonomous artificial intelligence (AI) for drug discovery. The collaboration aims to deepen the understanding of compound treatment mechanisms of action.
Plex Research will utilize its AI Platform with Ginkgo Datapoints' GDPx2 dataset, a large-scale transcriptomics survey measuring compound-induced gene expression across diverse human cells. This dataset is close to 4 terabytes in size and includes data from 4 human primary cell types, 85 compound treatments, 6 doses, and 4 replicates.
The combined capabilities are expected to unlock new, clinically relevant insights related to diseases and treatments, potentially revealing new therapeutic applications. This partnership represents a significant step in integrating robust data generation with innovative data analysis to accelerate biological research.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.